Glioblastoma News and Research

RSS
Glioblastoma is the most aggressive and malignant form of glioma, a type of primary brain cancer. Surgery is often used to treat gliomas, along with radiation. However, since surgery and radiation fail to cure the disease, doctors may turn to additional radiation or chemotherapy. In early stages glioblastoma tumors often grow without symptoms and therefore can become quite large before symptoms arise. When the tumor becomes symptomatic, tumor growth is usually very rapid and is accompanied by altered brain function, and if left untreated the disease becomes lethal. Although primary treatment is often successful in temporarily stopping the progression of the tumor, glioblastomas almost always recur and become lethal.
CytRx’s aldoxorubicin receives European orphan medicinal product designation for treatment of advanced soft tissue sarcomas

CytRx’s aldoxorubicin receives European orphan medicinal product designation for treatment of advanced soft tissue sarcomas

Cytrx releases statement in response to two recent lawsuits

Cytrx releases statement in response to two recent lawsuits

CytRx initiates Phase 3 clinical trial to evaluate efficacy of aldoxorubicin in STS patients

CytRx initiates Phase 3 clinical trial to evaluate efficacy of aldoxorubicin in STS patients

GenSpera enrolls  first patient in Phase II trial of compound G-202 in patients with glioblastoma multiforme

GenSpera enrolls first patient in Phase II trial of compound G-202 in patients with glioblastoma multiforme

FDA-approved anti-psychotic drugs possess tumor-killing activity against glioblastoma

FDA-approved anti-psychotic drugs possess tumor-killing activity against glioblastoma

Agenus reports net loss attributable to common stockholders of $5.8 million for Q4 2013

Agenus reports net loss attributable to common stockholders of $5.8 million for Q4 2013

Maximizing imaging techniques to bridge the gap between diagnosis and treatment of cancer

Maximizing imaging techniques to bridge the gap between diagnosis and treatment of cancer

Randomized trial of bevacizumab for glioblastoma shows disappointing results

Randomized trial of bevacizumab for glioblastoma shows disappointing results

Study identifies promising target for new drugs to treat lethal form of brain cancer

Study identifies promising target for new drugs to treat lethal form of brain cancer

Avastin can prolong the lives of women with advanced cervical cancer

Avastin can prolong the lives of women with advanced cervical cancer

Bevacizumab offers no benefit for patients newly diagnosed with glioblastoma

Bevacizumab offers no benefit for patients newly diagnosed with glioblastoma

Scientists develop mathematical method for classifying forms of glioblastoma

Scientists develop mathematical method for classifying forms of glioblastoma

Researchers use new technique that can partially move tumors from inoperable locations in brain

Researchers use new technique that can partially move tumors from inoperable locations in brain

Chemotherapy following radiation therapy improves survival for adults with brain tumor

Chemotherapy following radiation therapy improves survival for adults with brain tumor

IDH1 gene mutation determines best treatment for malignant astrocytomas

IDH1 gene mutation determines best treatment for malignant astrocytomas

TCGA Research Network identify new potential therapeutic targets for major form of bladder cancer

TCGA Research Network identify new potential therapeutic targets for major form of bladder cancer

Research shows promise for developing a method of clearly identifying cancerous tissue during surgery

Research shows promise for developing a method of clearly identifying cancerous tissue during surgery

First patient enrolled pilot clinical trial of NovoTTF Therapy plus gemcitabine for pancreatic adenocarcinoma

First patient enrolled pilot clinical trial of NovoTTF Therapy plus gemcitabine for pancreatic adenocarcinoma

Clinical trial of experimental vaccine targets cancer stem cells in patients with recurrent brain tumor

Clinical trial of experimental vaccine targets cancer stem cells in patients with recurrent brain tumor

CytRx initiates aldoxorubicin Phase 2 trial in HIV-infected patients with Kaposi's sarcoma

CytRx initiates aldoxorubicin Phase 2 trial in HIV-infected patients with Kaposi's sarcoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.